lung cancer

September 27, 2012

Photo: Lung Cancer Partnership

By VUMC News and Communications

September 21, 2012

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

By VUMC News and Communications

August 9, 2012

Study tracks how gene may promote lung cancer tumors

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

By VUMC News and Communications

August 2, 2012

VICC’s Hassanein lands lung cancer research grant

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer.

By VUMC News and Communications

March 23, 2012

Smoking stokes cells’ cancer capacity

Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.

By VUMC News and Communications

February 1, 2012

Drugs reverse lung cancer cell changes

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.

By VUMC News and Communications

December 7, 2011

Lung nodule surgery not always “futile”

Even when lung operations for suspected cancer resection results in a benign diagnosis, there still may be significant benefits to the procedure, new research suggests.

By VUMC News and Communications

April 15, 2011

Vanderbilt: Laboratory for health care reform

By Bill Snyder

March 24, 2011

Cancer Center study snuffs out menthol myths

People who smoke mentholated cigarettes are no more likely to develop lung cancer or die from the disease than are smokers of non-mentholated brands, a new study shows.

By Bill Snyder

March 3, 2011

Vanderbilt-Ingram Cancer Center launches online genetic research tool

A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.